Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN.

Takuma KatoHiromi HiramaKoji MitsuzukaSatoru MaruyamaHiroshi SasakiToshihiro SaitoRyuji MatsumotoShinichi SakamotoYasuyuki SakaiHiroshi FukuharaYukio NayaHiromasa TsukinoIsao HaraOsamu OgawaKatsuyoshi HashineFukuta FumimasaAkira YokomizoYoichiro TohiYoshiyuki KakehiMikio Sugimoto

Published in: Prostate cancer and prostatic diseases (2021)

This study is registered atthe Japan Trial Register with ID UMIN000009876 ( https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011573 ).

Keyphrases

prostate cancer
radical prostatectomy
randomized controlled trial
clinical trial
phase iii